|

Clemastine Fumarate Clinical Trials

3 actively recruiting trials across 2 locations

Also known as: Clemastine, Dayhist, Dayhist Allergy, Tavegyl, clemastine

Other1 trial

Clemastine Fumarate as Remyelinating Treatment in Internuclear Ophthalmoparesis and Multiple Sclerosis
Phase 3

San Francisco, California1 trial

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Sandler Neurosciences Building, Neurological Clinical Research Unit

Phase 1/2

Bethesda, Maryland1 trial

Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

National Institutes of Health Clinical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.